Skip to main content
. Author manuscript; available in PMC: 2018 Dec 25.
Published in final edited form as: Eur J Med Chem. 2018 May 10;154:117–132. doi: 10.1016/j.ejmech.2018.05.011

Scheme 3.

Scheme 3

Reagents and conditions: (a) pyridin-2-ylmethanamine (for the synthesis of 13a) or 2-(pyridin-2-yl)ethan-1-amine (for the synthesis of 13b), TBTU, NMM, CH2Cl2, rt, 15 h; (b) H2, Pd-C, MeOH, rt, 5 h; (c) 4,5-dibromopyrrole-2-carboxylic acid, oxalyl chloride, CH2Cl2, rt, 15 h, then ii) 14a-b, pyridine, CH2Cl2, rt, 15 h.